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Abstract
Background: Primary melanoma of the adrenal gland is exceptionally rare as demonstrated by the few cases
reported in the medical literature, and it has a high fatality rate. We present the case of a patient with two relapses
and survival to date.
Case report: We describe the case of a 58-year-old Caucasian woman who consulted her doctor with symptoms
of asthenia, anorexia and weight loss. A mass was palpated in her abdomen at the height of the left
hypochondrium. A computed tomographic scan revealed a retroperitoneal mass measuring 10 cm × 15 cm
originating in the left adrenal gland. A left nephroadrenalectomy and splenectomy were performed.
Histopathologically, the retroperitoneal mass corresponded to a melanoma, and no primary melanoma was found
in any other location. The patient was treated with interferon-a-2b. Three years after her diagnosis the patient
presented with a retroperitoneal relapse of the mass measuring 7.2 cm, which was removed. Five years after the
first relapse a new retroperitoneal relapse mass was diagnosed, which was also removed. Since then the patient
has been healthy and free from illness.
Conclusion: Histological and immunohistochemical studies, together with the criteria described by Ainsworth et al.
and Carstens et al., allowed us to diagnose primary melanoma of the adrenal gland.
Background
Primary melanoma of the adrenal gland is an exception-
ally rare occurrence, as demonstrated by the few cases
described in the medical literature [1-11]. Both primary
and metastatic melanomas of the adrenal gland are
rarely clinically evident, and in most cases they are inci-
dental findings. Generally, the signs and symptoms that
characterize these clinical entities are not at all specific,
with pain being the most common manifestation,
together with imprecise gastrointestinal disorders,
caused by the compression of the structures adjacent to
these neoplasias [12]. It is not unusual to come across
the typical symptoms of any tumor process, such as
asthenia, anorexia and weight loss.
Primary melanoma of the adrenal gland is usually a
voluminous, non-functional tumor showing heterogeneous
contrast enhancement on the computed tomographic
(CT) scan. The diagnosis is made on the basis of histologi-
cal and immunohistochemical studies.
The adrenal glands can be sites for the metastatic dis-
persal of cutaneous or visceral melanomas in up to 50%
of cases [13], and histological and immunohistochemical
studies do not make it possible to differentiate meta-
static tumors from primary melanomas. In 1976, Ains-
worth et al. [14] established a series of criteria for
establishing these differences. These criteria are (1) a
detailed clinical record indicating no prior existence of
cutaneous melanomas or cutaneous lesions that may
have reappeared, (2) careful cutaneous and ocular
exploration to eliminate the presence of lesions, (3) an
exhaustive evaluation to eliminate any other visceral
location, (4) a pattern of recurrence concordant with the
location site and (5) from the histological point of view,
non-typical melanocytes are usually seen on the periph-
ery of the lesions, which does not occur with secondary
melanomas. Subsequently, in 1984, Carstens et al. [4]
established other, similar criteria which make it possible
to diagnose a primary melanoma of the adrenal gland
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tochemical studies have been carried out. These criteria
are (1) neoplastic involvement of a single gland; (2)
absence of melanoma in the rest of the organism; (3)
absence of previous excisions of pigmented mucous,
cutaneous or ocular lesions; and (4) exclusion of any
hidden pigmented lesion, preferably by autopsy. Our
present case meets the Carstens et al. criteria, with the
exception of the last one, since our patient is still alive.
Primary involvement of the adrenal gland is extremely
rare. Only 23 patients have been described in the Eng-
lish-language literature, and documentation was com-
plete in only 11 of them [1-11] (Table 1).
In 1946, Kniseley and Baggentoss [1] published a case
and reviewed 11 cases known at that time, which had
not been completely researched because they failed to
meet the diagnostic criteria that were subsequently
established. In 1955, Dick et al. [2] published a new
case of melanoma of the adrenal gland that occurred
together with a pheochromocytoma, establishing the his-
tological differentiation between the two. Twelve years
later Sasidharan et al. [3] published an article describing
a primary melanoma of the adrenal gland in a 62-year-
old woman that was discovered during a routine medi-
cal examination. In 1984, Carstens et al. [4] reported a
case of a primary melanoma of the adrenal gland and
another of the lung, on the basis of which they estab-
lished a series of criteria for differentiating primary mel-
anoma of the adrenal glands from metastatic
melanomas. In 1990, Dao et al. [6] described two cases,
although only one of them met the criteria for primary
melanoma of the adrenal gland. They also reviewed the
literature and included four well-documented cases:
those published by Kniseley and Baggentoss [1], Dick et
al. [2], Sasidharan et al. [3] and Carstens et al. [4]. In
2000, Amérigo et al. [7] reported a new case and
reviewed the literature, including five well-documented
cases that had already been described. Up until that
time, there had been six perfectly documented cases. To
these well-documented cases, we add the case reported
by Parker and Vincent [5] in 1986, which had not been
described in the previous reviews. We include this case
because the CT scan, histopathology and meticulous
post-mortem study indicated that it met the criteria of
Carstens et al. [4]. In 2003, Zalatnai et al. [8] described
a primary melanoma of the adrenal gland in a 44-year-
old woman. In 2004, Granero et al. [9] described
another case in a 78-year-old man. Two years later, in
2006, two more cases were published: one by Liatsikos
et al. [10] in a 42-year-old man and another by Bastide
et al. [11] in a 33-year-old woman. We therefore have
gathered 11 well-documented case reports, which,
together with our present case, makes a total of 12
(Table 1).
The mean age of the patients in all of these 12 cases is
50.4 ± 17.2 years, with a median age of 49 years and an
age range between 24 and 78 years. Fifty percent of
these patients were men, and the initial mean size of the
tumors was 10.9 cm ± 3.8 cm with a median size of 10
cm and a range between 6 cm and 17 cm. The most fre-
quent symptom in these cases was pain (Table 1). Apart
from these cases described in the English-language lit-
erature, we found two cases in the Spanish-language lit-
erature, one of which was described by Deus Fombellida
et al. [12] and involved a 46-year-old woman, and
another described by Rodriguez Antolín et al. [15]
which involved a doubtful case in a 50-year-old man, in
which it is not clear whether the tumor was primary or
metastatic.
In this article, we report a new case of primary mela-
noma of the adrenal gland diagnosed on the basis of his-
tological and immunohistochemical studies and after
having excluded the presence of hidden pigmented
lesions. In 11 years of follow-up after the appearance of
the lesion, melanoma has not been found in any other
part of the patient’s body, which allows us to eliminate
a secondary or metastatic origin of the lesion.
Primary melanoma of the adrenal gland is treated by
surgery involving the complete removal of the tumor
and, nearly always, the removal of the adrenal gland and
kidney. Primary melanoma of the adrenal gland has a
high fatality rate; the patient described by Amérigo et al.
in 2000 [7] was still alive after 46 months of follow-up,
at the time the clinical case was published, and this
patient is still alive today. The patients in the rest of the
published cases survived less than 19 months after
surgery.
Case presentation
A 58-year-old Caucasian woman consulted her doctor
with symptoms of asthenia, anorexia and weight loss 15
days after they first appeared. In her physical examina-
tion, pallid skin and mucous membranes were observed.
Her abdomen was soft and yielding and tender to deep
palpation of the left hypochondrium, where a mass
could be felt.
In the medical tests carried out, the only altered para-
meters were hematocrit 24%, hemoglobin 8 g/dL, red
blood cell count 2,500,000/mm
3 and blood glucose 152
mg/dL. An abdominal ultrasound revealed a mass with
a diameter of approximately 10 cm at the area between
the tail of the pancreas, the left adrenal gland and the
upper pole of the left kidney. An abdominal CT scan
confirmed the presence of a large retroperitoneal tumor
measuring 10 cm × 15 cm that seemed to have its origin
in the left adrenal gland, which was surrounded by the
tumor, although the possibility of another type of pri-
mary retroperitoneal tumor could not be excluded
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pyelogram with contrast dye was obtained, which
revealed only a slight displacement of the left kidney in
relation to the described tumor. A chest X-ray did not
reveal any significant alterations.
We decided to perform surgery with the patient under
general anesthesia. We made a bilateral subcostal inci-
sion and found a large retroperitoneal tumor in the left
hypochrondrium with a grooved surface and a diameter
of approximately 15 cm. The tumor was removed,
including the kidney and left adrenal gland, together
with the spleen and greater omentum. The patient
recovered without any post-operative complications.
The anatomopathological study corresponded to a
tumor weighing 625 g and measuring 16 cm × 11 cm
with a nodular, fleshy appearance and areas of hemor-
rhage and necrosis. The microscopic study showed a
tumor with fusiform and ephithelioid cells, with fre-
quent multi-nucleation, monstrous nuclei, intra-nuclear
inclusions, prominent nucleoli and a high number of
mitoses, as well as a notable lymphocytic infiltrate. On
the periphery of the tumor, remnants of the adrenal
gland were recognizable, with tumor cells that had infil-
trated the wall of the large venous vessels.
Immunohistochemical staining revealed strong, diffuse
positive staining for S-100 protein and positive staining
Table 1 Reported cases of primary malignant melanoma of the adrenal gland
Reference Year Age Sex Location Size Clinical data Treatment Follow-up
Kniseley
and
Baggentoss
[1]
1946 60 M Left 8.5 cm × 4.5 cm
× 4.5 cm
Back pain, abdominal mass, anorexia Radiotherapy Died two
months after
detection
Dick et al.
[2]
1955 62 M Right 17 cm × 12 cm ×
10 cm
Painless, slowly growing mass Surgery without
specification
Died 15
months later
Sasidharan
et al. [3]
1977 52 F Left 13 cm × 10 cm ×
5c m
Asymptomatic; Well-defined, partly
mobile, non-tender, globular lump
confined to the left lumbar region
Adrenalectomy
and
nephrectomy
No follow-up
Carstens et
al. [4]
1984 32 F Left 14 cm × 9 cm ×
5c m
Pain in the left flank, weight loss Adrenalectomy
and
nephrectomy
Died seven
months later
Parker and
Vincent [5]
1986 77 M Right Asymptomatic. Casual finding in prostatic
patient. Extrinsic compression of the
proximal right ureter and displacement
of the collecting system and renal
contour laterally.
Autopsy
examination
Died two
months after
diagnosis
Dao et al.
[6]
1990 46 F Right 8 cm × 7 cm ×
6c m
Severe right flank pain Adrenalectomy
and
nephrectomy
Died one
month later
Amérigo et
al. [7]
2000 24 F Left 9 cm Intense post-prandial epigastric pain and
weight loss
Adrenalectomy
and
nephrectomy
Alive 46
months later
Zalatnai et
al. [8]
2003 41 F Left 7.3 cm × 6 cm Nausea, mild weight loss, abdominal
tenderness and constant left flank pain
Explorative
laparotomy
(non-resectable
tumor)
Died three
months later
Granero et
al. [9]
2004 78 M Right 11 cm Right flank pain, fever, nausea and
vomiting
Adrenalectomy,
nephrectomy
and
splenectomy
Alive 12
months later
Liatsikos et
al. [10]
2006 42 M Left 5.5 cm × 6 cm Mild flank pain, weight loss and anemia Laparoscopic
trans-peritoneal
adrenalectomy
Alive 12
months later
Bastide et
al. [11]
2006 33 M Right - Right paroxystic lumbar pain, mass in the
right flank
Adrenalectomy
and
nephrectomy
Died 18
months after
surgery
Present
case
2009 58 F Left 16 cm × 11 cm Asthenia, anorexia, weight loss, left
abdominal mass and anemia
Adrenalectomy,
nephrectomy
and
splenectomy
Local
recurrence,
alive 10 years
after first
surgery
Summary
statistics
50.4 ± 17.2
Median = 49
M=
50.0%
Left =
58.3%
10.9 cm ± 3.8 cm
Median = 10 cm
Range = 6 cm to
17 cm
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ing for vimentin was also positive. Staining for the
epithelial markers cytokeratin (CAM 5.2) and epithelial
membrane antigen and the neuroendocrine markers
chromogranin A and synaptophysin were negative. A
diagnosis of non-pigmented melanoma was established
(Figure 2).
After the patient’s release from our hospital, an
exhaustive examination was conducted by dermatolo-
gists, ophthalmologists and oncologists, who found no
evidence of lesions suggestive of melanoma in any part
of her body. The patient was treated and her records
were reviewed by the oncology department. Her treat-
ment consisted of interferon-a-2b (IFNa2b) adminis-
tered intravenously. Analytical and radiological reviews
(abdominal CT scan and chest X-ray) were carried out.
Thirty-two abdominal CT scans were obtained through-
out this period, making it possible to diagnose and treat
relapses in a relatively timely manner.
Two years after the patient’s diagnosis and surgery,
during a routine review involving an abdominal CT
scan, a solid retroperitoneal mass with areas of necrosis
measuring 7 cm × 2 cm × 4.5 cm was found in the left
renal fossa, invading the abdominal wall and in direct
contact with the intestinal loops. Also, a para-aortic
adenopathy with a diameter of 1.8 cm was observed
(Figure 3).
The patient once again underwent surgery while under
general anesthesia. We performed a mid-line suprain-
fraumbilical incision and located a tumor in the pre-
vious surgical area. Its diameter was approximately 10
cm, it seemed to infiltrate the abdominal wall and it was
adhered to the splenic angle of the colon, although with-
out infiltration. After the adhesions were removed, we
completely removed the tumor, together with a para-
aortic adenopathy with a diameter of approximately 3
cm. The post-operative period progressed without any
incidents. The pathology of the retroperitoneal lesion
Figure 1 Tumor measuring 10 cm × 15 cm in the upper region of the peri-nephric space.T h et u m o r ’s origin appears to be in the left
suprarenal gland, which is surrounded by the mass.
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Figure 2 (A) Histopathology of the primary and recurrent tumor showing a solid mass with nests of cells with an epithelioid
appearance and eosinophilic cytoplasm (hematoxylin and eosin stain; original magnification, × 400). Immunohistochemical stains for S-
100 protein showed (B) an intense diffuse positivity, and (C) HMB-45 and (D) MELAN A were also diffusely positive.
Figure 3 Image showing a solid mass measuring 7.2 cm × 4 cm with areas of necrosis, situated in the retroperitoneum and invading
the wall of the abdomen, in contact with the intestinal loops. The para-aortic adenopathy measured 1.8 cm.
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the one previously excised.
Four years after the initial diagnosis, during a radiolo-
gical review (chest X-ray and CT scan), pulmonary
nodules were detected that were suggestive of pulmon-
ary metastasis. Chemotherapy with dacarbazine and
IFNa2b was begun by the oncology service, and one
year later the CT scan revealed that the nodules had
disappeared.
In the CT scan obtained eight years after the initial
diagnosis, we observed a nodule measuring 4.5 cm × 2.3
cm in the left renal fossa and a nodule measuring 2.5
cm × 2.5 cm in the mesenteric fat of the descending
c o l o n( F i g u r e4 ) .O nt h eb a s i so ft h e s ef i n d i n g s ,w e
decided to perform surgery with the patient under gen-
eral anesthesia to remove the nodules through a left
subcostal incision, including the tail of the pancreas and
the splenic angle of the colon, re-establishing intestinal
continuity by colocolic anastomosis. The tumor
remained unchanged in its microscopic appearance.
During the subsequent clinical and radiological follow-
up, no relapse was observed.
Discussion
Primary melanoma is a tumor that is most frequently
found on the skin and which, on very rare occasions,
may originate in the eye (choroid plexus). Melanomas
have also been found in the mouth cavity, larynx and
bronchi, the esophagus, the rectum, the genitourinary
system, the meninges, the ovaries, the uterine cervix, the
vagina and the adrenal glands. One of the major obsta-
cles for clinicians is identifying whether the tumor is
really a primary tumor or whether it is metastatic [13].
The possibility exists that a tumor lesion of melanocy-
tic cells in the skin or eyes may have gone unnoticed or
that a skin lesion removed months or years ago may
have been the primary origin of undiagnosed melanoma.
Also, some authors have mentioned that primary skin
melanoma occasionally reappears spontaneously, and
the only clinical symptoms in some of these patients are
due to the presence of metastasis in the regional lym-
phatic ganglia or the internal organs [16-19]. Some
authors have even described the total or partial sponta-
neous regression of melanoma metastasis after bilateral
adrenalectomy, which may be partly explained by the
fact that human melanoma cells have a high affinity for
glucocorticoid receptors. For this reason, adrenalectomy
has been shown to have anti-melanoma effects in ani-
mals [19].
The adrenal medullary blasts and melanoblasts have a
common embryological origin at the neuroectodermal
level [20], similarly to the nervous system and the skin.
As a result, ectopic melanocytes can exist in this
location and cause metaplasia and malignant transfor-
mation, leading to the appearance of a melanoma. This
would explain why primary melanoma can originate in
the adrenal glands. Primary melanoma of the adrenal
gland raises the need for a differential diagnosis, espe-
cially in cases of metastatic melanoma and pigmented
pheochromocytoma. Pigmented adrenal adenoma, adre-
nal hematoma and adrenocortical carcinoma have to be
considered in the differential diagnosis, too.
In primary melanomas, the four stages of melanogenesis
are usually observed [21]. With regard to the differential
diagnosis of pigmented pheochromocytoma, immunohis-
tochemical studies are necessary, essentially with the neu-
roendocrine markers chromogranin and synaptophysin,
and electron microscopy is also required [11]. Pigmented
pheochromocytoma shows immunoreactivity for chromo-
granin, synaptophysin and enolase. In one case series, it
was found that in one-third of the cases of pheochromocy-
toma, there were HMB45-positive cells, which comes as
no surprise because the cells of the adrenal medulla or
pheochromocytes are derived from the neural crest in the
same way as melanocytes, and HMB45 antibody stains
tumors derived from the neural crest. In the pheochromo-
cytoma, there are a number of sustentacular cells on the
periphery of the tumor nests, which are stained with S-
100. No positivity has been described for Melan-A. By
using an electron microscope, neurosecretory granules can
be detected in the cytoplasm. In melanoma, the cells are
not stained with chromogranin or synaptophysin, and
neither is there positivity for catecholamines, enolase and
opioid peptides, which are typical pheochromocytoma
markers. Melanoma tumor cells are stained with Melan-A
and also with HMB45 and S-100. By using an electron
microscope, pre-melanosomes or melanosomes can be
detected [8-22].
Because at the macroscopic level the melanoma may
have a brown or black color, it is necessary to also
establish the differential diagnosis with other pigmented
adrenal lesions such as pigmented adrenal adenomas
[23]. These are tumors of the adrenal cortex, which are
benign and small, usually measuring less than 5 cm.
Microscopic and immunohistochemical studies lead to
t h ec o r r e c td i a g n o s i s .T h e s et u m o r sa r eu s u a l l yp o s i t i v e
for low-molecular-weight keratins, but not for the mar-
kers S-100 and HMB45 [23].
At the macroscopic level, adrenal hematomas may also
give rise to confusion; however, under the microscope,
hemosiderin-laden macrophages may be seen, and the
histological characteristics are completely different.
Adrenocortical carcinomas are tumors that require the
establishment of a differential diagnosis. It is a larger-
sized tumor than the adenoma, and its cells do not stain
positively for S-100 or HMB45 [23].
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The clinical case we present herein meets the criteria of
Ainsworth et al. [14] and Carstens et al. [4]. The tumor
affected a single gland (the left adrenal gland), mela-
noma was found to be absent in the rest of the organ-
ism based on exhaustive dermatological, digestive,
ophthalmological and urological examinations, and there
was no history of the removal of pigmented lesions. The
relapses that were treated surgically were always locore-
gional, and from a histological and immunohistochem-
ical perspective, they had the characteristics of
melanoma. Also, the fact that 11 years have passed since
Figure 4 Image showing a lesion measuring 2.3 cm × 4 cm situated behind and beneath the tail of the pancreas and a lesion
measuring 2.5 cm × 2.5 cm situated in the mesenteric fat adjacent to the medial border of the descending colon, compatible with
tumor implants.
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other location leads us to the conclusion that our
patient’s lesion was a primary melanoma of the adrenal
gland.
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